National Health Investors Posts Higher Revenue, Net Income and Diluted EPS Across Both Interim Windows

Bottom line

Across both reporting windows covered in this interim filing, National Health Investors, Inc. posted higher revenue, higher net income attributable to parent, and higher diluted earnings per share year over year on an authorized basis, with each line item remaining profitable versus the prior-year comparables.

Reporting-period identity. The filing is the company's 10-Q for the period-ended-2026-06-30 of fiscal year period-ended-2026-06-30, filed under accession 0000877860-26-000199 by the registrant identified as NATIONAL HEALTH INVESTORS INC with CIK 0000877860 and ticker NHI. Two reporting windows are presented inside the same interim document: a three-month period for the quarter ended the three months ended June 30, 2026 alongside the prior-year quarter ended the three months ended June 30, 2025, and a six-month year-to-date period ended the six months ended June 30, 2026 alongside the prior-year year-to-date period ended the six months ended June 30, 2025. Because the source narrative explicitly states that interim results are not necessarily indicative of full-year results, the figures discussed here are confined to those two windows and their year-over-year directionality.

Source scope and basis of presentation. The financial line items that anchor this section come from the condensed consolidated statements of income within the unaudited interim financial statements prepared in accordance with U.S. GAAP, as described in the cited note on significant accounting policies and basis of presentation. The filing notes that certain prior-year amounts have been reclassified to conform with the current-period presentation, and the reader is directed to read these interim statements alongside the audited annual report on the company's prior annual report filed with the SEC. The business description, included as part of the cited note on the description of the business, frames National Health Investors as a real estate investment trust operating through two reportable segments — Real Estate Investments and Senior Housing Operating Portfolio — focused on senior housing communities and medical facilities across the United States, with operations outsourced to third-party managers and certain properties held in consolidated partnerships with noncontrolling interests. Property and unit counts referenced elsewhere in the filing are stated to be outside the scope of the independent registered accounting firm's review and are therefore not treated as audited facts in this analysis.

Three-month window. For the quarter ended the three months ended June 30, 2026, the filing reports Revenue from Contract with Customer, Excluding Assessed Tax of $44,779,000 USD, Revenues of $121,319,000 USD, Net Income (Loss) Attributable to Parent of $55,671,000 USD, and Earnings Per Share, Diluted of $1.15 per diluted share USD/SHARES, each higher than the prior-year quarter ended the three months ended June 30, 2025 comparative values of $14,217,000 USD, $90,662,000 USD, $36,987,000 USD, and $0.79 per diluted share USD/SHARES, respectively, with the transition remaining profit to profit on a per-share and net-income basis.

Six-month year-to-date window. For the six-month year-to-date period ended the six months ended June 30, 2026, the filing reports Revenue from Contract with Customer, Excluding Assessed Tax of $81,839,000 USD, Revenues of $236,449,000 USD, Net Income (Loss) Attributable to Parent of $95,773,000 USD, and Earnings Per Share, Diluted of $1.97 per diluted share USD/SHARES, each higher than the prior-year year-to-date period ended the six months ended June 30, 2025 comparative values of $28,156,000 USD, $179,958,000 USD, $71,152,000 USD, and $1.53 per diluted share USD/SHARES, respectively, with the transition again remaining profit to profit.

Direction attribution. The filing evidence does not attribute this change to any single cause.

Financial performance

- Reported results frame. The filing under 10-Q for period-ended-2026-06-30 (accession 0000877860-26-000199, CIK 0000877860, ticker NHI) presents two reporting windows: the three-month reporting period the three months ended June 30, 2026 and the six-month year-to-date period the six months ended June 30, 2026. Management cautions in the cited note that interim results are not necessarily indicative of full-year outcomes and that the condensed statements should be read alongside the audited annual report referenced in Note 2.

The entity description is carried in Note 1, with Note 4 covering real-estate property accounting and Note 6 and Note 17 speaking to equity-method and VIE matters referenced elsewhere in the filing. - Year-over-year movement (reported). Across both windows, the headline measures trend upward against the prior-year comparative.

53 per diluted share). Net Income (Loss) Attributable to Parent is similarly higher, again with a profit-to-profit transition in both windows (per $55,671,000, $36,987,000, $95,773,000, and $71,152,000). Revenue from Contract with Customer, Excluding Assessed Tax and the broader Revenues line are both higher in both windows versus their prior-year comparatives (per $44,779,000, $14,217,000, $81,839,000, $28,156,000, $121,319,000, $90,662,000, $236,449,000, and $179,958,000).

No quarter-versus-quarter sequential comparison is authorized for this section. - Accounting context. The accounting policies in Note 2 establish that the interim statements are GAAP, unaudited, and use the same principles of consolidation and equity-method treatment applied in prior periods.

The cited note also flags that certain prior-year amounts were reclassified within the condensed balance sheet and within operating cash flows to conform to current-period presentation, a factor that can shape how readers reconcile the comparatives without altering the underlying totals. Revenue recognition policy describes straight-line rental income for real-estate leases and resident fees and services revenue for the SHOP segment, with contingent rent recognized only when thresholds are exceeded and collectability reassessed regularly.

- Guidance and forward expectations. The cited narrative does not present quantified forward guidance for revenue, earnings, or dividends, nor does it provide peer or industry benchmarks. The filing evidence does not attribute this change to any single cause.

- Unknowns and counter-evidence. No peer data is supplied. The filing evidence contains no peer or industry comparison.

No counter-evidence within the filing contradicts the authorized direction of the headline measures across the two windows; quarterly sequential direction is not in scope for this section. Readers looking to cross-check interim reading habits against a comparable interim result can consult the recent Lizely Finance Earnings Analysis — Veru Inc. (VERU) Interim Filing: Losses Persist With Mixed Year-over-Year Direction piece, which illustrates a different profit-versus-loss shape than this section encounters.

Operating drivers and segments

- Two reportable segments are described: Real Estate Investments and Senior Housing Operating Portfolio ("SHOP"), with rental income tied to the Real Estate Investments segment and resident fees and services tied to the SHOP segment. - The Real Estate Investments segment houses triple-net leases that generally include fixed annual rent escalators and contingent rent above tenant-revenue thresholds; SHOP revenue is generated under independent unit-level agreements at owned senior housing communities. - Property composition disclosed in the narrative covers assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, hospitals and independent living facilities, plus a small pool of assets held for sale and a subset held through consolidated partnerships with manager-affiliated noncontrolling interests. - Two parallel revenue series appear in the income statement, both labeled for the three-month reporting period and the six-month year-to-date period, each carrying prior-year comparatives: "Revenue from Contract with Customer, Excluding Assessed Tax" (drawn from the contract-with-customer line items) and a separate "Revenues" series, suggesting reclassification activity between windows that the reader should treat as presentation-driven rather than as new business. - Quarter and half-year revenue values, on both the contract-with-customer series and the reclassified Revenues series, rose versus the prior-year comparative on both reported windows, with the directionally higher six-month and quarterly readings supporting a stable top-line pace.

- Management frames the operating model around owning, leasing and operating senior housing communities and medical facilities in the United States, with SHOP properties managed by third parties for a fee and Real Estate Investments leased to healthcare operators, while a portion of SHOP properties is held through consolidated partnerships with manager-affiliated noncontrolling interest holders. - Management explains the revenue lines by tying rental income to straight-line recognition under triple-net leases, with contingent rent recognized once tenant revenues cross contractual thresholds, and by tying resident fees and services to independent agreements on each SHOP residential unit, citing the lessor practical expedient that combines lease and non-lease components under the cited lease accounting standard. - The accounting policy discussion notes reclassifications to certain balance sheet line items and operating cash flow lines so prior periods conform to the current presentation, which is the most plausible explanation for the parallel "Revenue from Contract with Customer" and "Revenues" series appearing for both the current and prior-year windows. - Property-count narrative carries an explicit caveat that those counts sit outside the scope of the independent registered accounting firm's review, which is relevant when weighing any operating-driver claim built on unit counts. - For the revenue move itself, The filing evidence does not attribute this change to any single cause.. - No peer or industry benchmark is presented in the filing evidence, so any read on margin pressure versus competitors cannot be supported here: The filing evidence contains no peer or industry comparison..

Readers cross-checking interim filings where revenue is re-presented alongside a parallel Revenues line can compare the structure against another REIT-style reporting cycle, such as Lizely Finance Earnings Analysis — Veru Inc. (VERU) Interim Filing: Losses Persist With Mixed Year-over-Year Direction, to see how reclassification effects show up in adjacent healthcare and senior-housing stories.

Cash flow and capital

Reported facts: - Net Cash Provided by (Used in) Operating Activities for the six-month year-to-date period is reported as a positive figure under $118,413,000, compared with a positive figure under $106,295,000 for the prior-year comparative six-month window; the reported comparison indicates an increase versus the prior year. - Net Cash Provided by (Used in) Investing Activities for the current six-month window is reported as a negative figure under -$147,300,000, against a negative figure under -$123,785,000 for the prior-year six-month window; the reported comparison indicates a decrease (that is, larger net outflows) versus the prior year. - Net Cash Provided by (Used in) Financing Activities for the current six-month period is reported as a positive figure under $59,697,000, against a positive figure under $10,311,000; the reported comparison indicates an increase versus the prior year. - Payments of Dividends for the current six-month period is reported as a positive figure under $89,021,000, against a positive figure under $83,143,000; the reported comparison indicates an increase versus the prior year. - On the balance sheet at the balance sheet date of June 30, 2026, Cash and Cash Equivalents, at Carrying Value is reported as $30,388,000, and Accounts Payable and Accrued Liabilities is reported as $46,437,000.

Management explanations: - The quoted narrative focuses on accounting policy rather than management commentary on the cash flow statement itself. Topics covered in Note 2 and Note 4 include lease incentive capitalization, resident fee recognition under the resident-agreement practical expedient, interest income accrual on mortgage and other notes receivable, asset-acquisition accounting for real estate purchases, and impairment monitoring for long-lived assets. None of the quoted excerpts offer a management rationale for the period-over-period cash flow movements.

Analyst inference: - The current six-month window shows operating cash flow moving higher, investing outflows widening, financing inflows rising, and dividend payments moving higher relative to the prior-year six-month window. A wider investing outflow alongside higher financing inflows is consistent with continued deployment into property investments funded by external sources, and the dividend rise is consistent with the higher Payments of Dividends line. The filing evidence does not attribute this change to any single cause.

Counter-evidence: - The filing evidence does not attribute this change to any single cause.

Unknowns: - The filing evidence does not provide a breakdown of financing inflows between debt issuance, repayments, or equity activity, nor does it segment investing outflows between acquisitions, development, or mortgage-funding activity. The composition of Payments of Dividends versus prior year is also not detailed in the quoted excerpts. Peer or industry cash flow comparisons are not available: The filing evidence contains no peer or industry comparison.

Peer and historical context

- The filing evidence for NATIONAL HEALTH INVESTORS INC's 10-Q for period-ended-2026-06-30 contains no peer or industry comparison, so any read-across to other healthcare real estate investment trusts or triple-net lease operators cannot be drawn from this filing alone. The filing evidence contains no peer or industry comparison. - Looking inward at the company's own reported history, the three-month period the three months ended June 30, 2026 shows Revenue from Contract with Customer, Excluding Assessed Tax of $44,779,000 USD, compared with $14,217,000 USD for the three months ended June 30, 2025; the half-year the six months ended June 30, 2026 shows $81,839,000 USD versus $28,156,000 USD for the six months ended June 30, 2025.

On both windows the direction is higher than the prior period, with revenue staying positive in both the current and prior periods. - The legacy Revenues line tells the same story from a different presentation: $121,319,000 USD for the three months ended June 30, 2026 versus $90,662,000 USD for the three months ended June 30, 2025, and $236,449,000 USD for the six months ended June 30, 2026 versus $179,958,000 USD for the six months ended June 30, 2025, each higher than the prior period. - Net Income (Loss) Attributable to Parent follows a parallel pattern, with the three-month the three months ended June 30, 2026 figure of $55,671,000 USD up from $36,987,000 USD for the three months ended June 30, 2025, and the half-year the six months ended June 30, 2026 figure of $95,773,000 USD up from $71,152,000 USD for the six months ended June 30, 2025.

In each case the current and prior periods are both profit, with the transition remaining profit to profit. - Cash generation is consistent with that profitability picture: Net Cash Provided by (Used in) Operating Activities was $118,413,000 USD for the six months ended June 30, 2026, higher than $106,295,000 USD for the six months ended June 30, 2025, and the figure remains positive on both ends of the comparison. - The accounting-policy discussion in the cited notes explains how the revenue line is built — resident fees and services recognized under the cited revenue recognition standard, with interest income from mortgage and other notes recognized as earned — but it does not isolate a single driver behind the year-over-year change.

The filing evidence does not attribute this change to any single cause. - Nothing in the cited notes reframes the comparative numbers; reclassifications, where noted, do not appear to reverse the direction of growth on either revenue presentation.

Scenario analysis

The conditional scenarios below are framed around the directional moves that the filing evidence already authorizes, anchored to the revenue and net income lines presented in the 10-Q filed under accession 0000877860-26-000199 for NATIONAL HEALTH INVESTORS INC (NHI) covering the the three months ended June 30, 2026 and the the six months ended June 30, 2026.

Reported facts: - Revenue from Contract with Customer, Excluding Assessed Tax was higher than the prior-year comparative on both reporting windows, with $81,839,000 USD for the the six months ended June 30, 2026 versus $28,156,000 USD for the the six months ended June 30, 2025, and $44,779,000 USD for the the three months ended June 30, 2026 versus $14,217,000 USD for the the three months ended June 30, 2025. - A second Revenues line was also higher on both windows, with $236,449,000 USD for the the six months ended June 30, 2026 versus $179,958,000 USD for the the six months ended June 30, 2025, and $121,319,000 USD for the the three months ended June 30, 2026 versus $90,662,000 USD for the the three months ended June 30, 2025. - Net Income (Loss) Attributable to Parent was higher than the prior-year comparative on both windows, with $95,773,000 USD for the the six months ended June 30, 2026 versus $71,152,000 USD for the the six months ended June 30, 2025, and $55,671,000 USD for the the three months ended June 30, 2026 versus $36,987,000 USD for the the three months ended June 30, 2025. Both periods remained profitable.

Management explanations and disclosed accounting posture: - The cited accounting note describes the straight-line depreciation framework for buildings and improvements, the conditions for reclassifying real estate properties to assets held for sale, the lower-of-carrying-or-fair-value remeasurement at the time of that classification, and a market-approach valuation methodology that draws on binding sale agreements, purchase offers received, broker quotes and third-party valuations. Credit-loss reserves on mortgage and other notes receivable are described as being established at inception and reassessed quarterly, with collective modeling for mortgage and construction loans and individual or borrower-specific modeling for mezzanine loans and revolving lines of credit, incorporating payment status, borrower financial strength, historical write-offs, collateral coverage, and current economic and forecast adjustments. - The filing evidence does not attribute this change to any single cause.

Analyst inference (conditional scenarios built only on the authorized directions):

- Revenue and net income continue to track higher on both reporting windows, consistent with the $81,839,000 vs $28,156,000 comparison, the $44,779,000 vs $14,217,000 comparison, the $236,449,000 vs $179,958,000 comparison, the $121,319,000 vs $90,662,000 comparison, the $95,773,000 vs $71,152,000 comparison, and the $55,671,000 vs $36,987,000 comparison. - Real estate carrying values are anchored by the lower-of-carrying-or-fair-value remeasurement policy described in the cited note and by the stated useful-life ranges for buildings and improvements. - Mortgage and other notes receivable credit exposure is modeled under the disclosed reserve methodology, with construction loans evaluated on a collective basis and the others on an individual or borrower-specific basis.

- Both revenue lines extend their higher-than-prior-period path and the net income figures extend their higher-than-prior-period path, preserving the profit-to-profit transitions on the three-month and six-month windows. - Remeasurement events tied to assets held for sale, and any subsequent reclassification back to held and used, are resolved favorably relative to the disclosed market-approach framework, supporting the carried real estate base. - Reserves on mortgage and other notes receivable are released or adjusted upward as the disclosed credit-quality indicators and probability-of-default overlays improve relative to the prior-period assumptions.

- Revenue growth on either window decelerates or reverses relative to the prior-year comparative on the lines reported as $81,839,000 vs $28,156,000, $44,779,000 vs $14,217,000, $236,449,000 vs $179,958,000, and $121,319,000 vs $90,662,000. - Net income compresses on the windows comparing $95,773,000 to $71,152,000 and $55,671,000 to $36,987,000. - Indicators of potential impairment described in the cited note trigger the undiscounted-cash-flow-versus-carrying test and, if needed, a charge recognized in loan and realty gains, net; mortgage and other notes receivable reserves expand under the probability-of-default overlays and the collateral-coverage and payment-status inputs. - The filing evidence does not attribute this change to any single cause.

Counter-evidence: - The filing evidence does not present segment-level detail, so the upside and downside paths cannot be re-allocated across operating segments. The filing evidence does not disclose segment-level detail for this dimension. - The filing evidence does not include any peer or industry comparison that would reframe these directional moves. The filing evidence contains no peer or industry comparison. - The cited accounting note does not attribute the year-over-year revenue or net income movements to any single cause. The filing evidence does not attribute this change to any single cause.

Unknowns: - The split between the two reported revenue lines on each window is not disclosed in a way that lets the reader attribute the higher-than-prior-period outcome to one component versus the other, and the filing evidence does not state a cause for the gap. The filing evidence does not attribute this change to any single cause. - The size and direction of any quarterly credit-loss reserve movement are not disclosed in the filing evidence, so the reserve-release upside and reserve-build downside paths remain conditional rather than quantified.

Risks and what to watch

- Forward-looking risks drawn from the filing, the management discussion, the analyst interpretation, any counter-evidence in the document, and the genuine unknowns. The reader-facing prose below is grounded in the FACT, PERIOD, IDENTITY, and REFERENCE keys listed in the placeholder catalog; numbers are inserted by the machine after drafting.

Reported facts are limited to the comparative revenue and net income figures visible in the consolidated statements of income for NATIONAL HEALTH INVESTORS INC under 10-Q for period-ended-2026-06-30 (accession 0000877860-26-000199, CIK 0000877860, ticker NHI). - Revenue from Contract with Customer, Excluding Assessed Tax is reported as $44,779,000 for the three months ended June 30, 2026 and $81,839,000 for the six months ended June 30, 2026, with prior-year comparatives of $14,217,000 for the three months ended June 30, 2025 and $28,156,000 for the six months ended June 30, 2025. - A second revenue line titled Revenues is also reported as $121,319,000 for the three months ended June 30, 2026 and $236,449,000 for the six months ended June 30, 2026, against prior-year comparatives of $90,662,000 for the three months ended June 30, 2025 and $179,958,000 for the six months ended June 30, 2025. - Net Income (Loss) Attributable to Parent is reported as $55,671,000 for the three months ended June 30, 2026 and $95,773,000 for the six months ended June 30, 2026, against prior-year comparatives of $36,987,000 for the three months ended June 30, 2025 and $71,152,000 for the six months ended June 30, 2025.

Management's commentary on credit-loss reserves for mortgage and other notes receivable is set out in Note 5, covering the recognition of deferred commitment fees, discounts and premiums; amortization under the effective interest method; treatment of early repayments; and the quarterly collective- or individual-basis reserving models, including borrower-specific indicators and probability-of-default adjustments for current economic conditions. - The basis of presentation, including reclassifications referenced elsewhere in the statements, is described in Note 2. - The real estate property accounting policy underlying the portfolio is described in Note 4. - Equity-method investment and consolidation disclosures affecting the period's scope are addressed in Note 6 and Note 17. - The business description framing the consolidated entity is set out in Note 1.

Across every authorized comparison in the catalog, current-period results are higher than the prior period: Revenue from Contract with Customer, Revenues, and Net Income (Loss) Attributable to Parent all show an authorized increase on both the three-month and six-month windows; diluted EPS retains a profit-to-profit transition on both windows; and operating and financing cash flow lines likewise show authorized increases while investing cash flow shows an authorized decrease, with dividend payments also higher. - The credit-loss policy in Note 5 ties the loan-loss reserving model to current payment status, borrower strength, write-off history, collateral coverage, and forward-looking economic adjustments, which is the principal area where management judgement can move reported results between quarters.

No counter-evidence appears in the filing: every authorized direction is an increase on the revenue, net income, and EPS comparisons, with no negative direction listed in the catalog. - The presence of two parallel revenue lines (Revenue from Contract with Customer, Excluding Assessed Tax and Revenues) suggests a possible reclassification or presentation difference versus the prior period, consistent with the reclassifications note flagged in Note 2 and Note 6.

The filing evidence does not attribute this change to any single cause. - The filing evidence contains no peer or industry comparison. - The filing evidence does not disclose segment-level detail for this dimension. - Specific exposure to any single borrower, the geographic concentration of the collateralized loans referenced in Note 5, and the size of any individual credit-loss reserve change are not stated in the filing evidence and cannot be quantified from the available FACT keys.

METRICS TO WATCH NEXT PERIOD - Quarterly movement in Revenue from Contract with Customer, Excluding Assessed Tax and Revenues, to confirm whether the dual-line presentation persists and how each line moves against its prior-year comparative. - Net Income (Loss) Attributable to Parent on both the three-month and six-month windows, given the authorized profit-to-profit transition. - Diluted EPS on both windows, where the catalog again records an authorized profit-to-profit increase. - Operating, investing, and financing cash flow lines on the six-month comparison, including dividend payments, where the catalog records authorized increases for operating, financing, and dividends, and an authorized decrease for investing. - Credit-loss reserves on mortgage and other notes receivable under the policy described in Note 5, since changes flow through loan and realty gains, net. - Risk-factor and legal-proceedings updates carried in Item 1A and Item 1, and any new disclosures in the controls, market-risk, and exhibits sections referenced by Item 3, Item 4, Item 5, and Item 6. - Readers comparing interim filings across the sector can contrast this period with the interim trajectory described in Lizely Finance Earnings Analysis — Veru Inc. (VERU) Interim Filing: Losses Persist With Mixed Year-over-Year Direction.